D. DOĞRU ERSÖZ Et Al. , "Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial," ECFS Conference , 2004
DOĞRU ERSÖZ, D. Et Al. 2004. Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial. ECFS Conference .
DOĞRU ERSÖZ, D., DALGIÇ, F., KİPER, E. N., ÖZÇELİK, H. U., YALÇIN, E. E., ASLAN, A. T., ... NERMİN, G.(2004). Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial . ECFS Conference
DOĞRU ERSÖZ, DENİZ Et Al. "Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial," ECFS Conference, 2004
DOĞRU ERSÖZ, DENİZ D. Et Al. "Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial." ECFS Conference , 2004
DOĞRU ERSÖZ, D. Et Al. (2004) . "Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial." ECFS Conference .
@conferencepaper{conferencepaper, author={DENİZ DOĞRU ERSÖZ Et Al. }, title={Effect Of Clarithromycin on Inflammatory Markers in Bronchoalveolar Lavage Fluid in Cystic Fibrosis: A Randomised, Placebo-Controlled Crossover Trial}, congress name={ECFS Conference}, city={}, country={}, year={2004}}